Autologous tumor-cell vaccination and lymphokine-activated tumor-infiltrating lymphocytes (LAK-TIL).
Mallmann
P
P
Department of Gynecology and Obstetrics, University of Bonn, Germany.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy; D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000302:isolation & purification; D003602:Cytotoxicity, Immunologic; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D009522:Newcastle disease virus; D010051:Ovarian Neoplasms / Q000276:immunology / Q000628:therapy*; D014407:Tumor Cells, Cultured / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage / Q000302:isolation & purification
D000951:Antigens, Neoplasm; D007376:Interleukin-2; D014612:Vaccines